Bioengineered Carboxymethylcellulose-Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic-Magnetothermal Therapy of Brain Cancer Cells.

MLA

Mansur, Alexandra A. P., et al. “Bioengineered Carboxymethylcellulose-Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic-Magnetothermal Therapy of Brain Cancer Cells.” Pharmaceutics, vol. 14, no. 10, Oct. 2022. EBSCOhost, https://doi.org/10.3390/pharmaceutics14102223.

APA

Mansur, A. A. P., Carvalho, S. M., Oliveira, L. C. A., Souza-Fagundes, E. M., Lobato, Z. I. P., Leite, M. F., & Mansur, H. S. (2022). Bioengineered Carboxymethylcellulose-Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic-Magnetothermal Therapy of Brain Cancer Cells. Pharmaceutics, 14(10). https://doi.org/10.3390/pharmaceutics14102223

Chicago

Mansur, Alexandra A P, Sandhra M Carvalho, Luiz Carlos A Oliveira, Elaine Maria Souza-Fagundes, Zelia I P Lobato, Maria F Leite, and Herman S Mansur. 2022. “Bioengineered Carboxymethylcellulose-Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic-Magnetothermal Therapy of Brain Cancer Cells.” Pharmaceutics 14 (10). doi:10.3390/pharmaceutics14102223.